Agonist-mediated docking of androgen receptor onto the mitotic chromatin platform discriminates intrinsic mode of action of prostate cancer drugs.
Kumar S, Chaturvedi NK, Kumar S, Tyagi RK, Biochim Biophys Acta, 2008 Jan - link